Related Experiment Video
Updated: May 12, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic obstructive pulmonary disease--a treatable disease
Mirjam Osthoff1, Christine Jenkins, Jörg D Leuppi
1Clinic of Internal Medicine, University Hospital Basel, Switzerland; miosthoff@uhbs.ch.
Smoking cessation is key for chronic obstructive pulmonary disease (COPD). Long-acting bronchodilators are mainstays, with inhaled corticosteroids for frequent exacerbations, aligning with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue with smoking as the primary risk factor.
- Diagnosis relies on symptoms, exacerbation risk, and lung function tests, using a post-bronchodilator FEV1/FVC ratio <0.7 and GOLD staging.
- The Global Initiative for the Diagnosis, Management, and Prevention of COPD (GOLD) strategy guides therapeutic recommendations.
Purpose of the Study:
- To review current therapeutic options for COPD in line with the GOLD strategy.
- To discuss controversies surrounding pharmacotherapy's role in COPD management and its impact.
- To cover non-pharmacological treatments, vaccines, and disease management programs for COPD.
Main Methods:
- Literature review focusing on therapeutic strategies for COPD.
- Analysis of treatments based on disease severity, symptoms, and exacerbation risk.
- Inclusion of evidence for pharmacological and non-pharmacological interventions.
Main Results:
- Smoking cessation is the most effective intervention across all COPD stages.
- Long-acting bronchodilators (antimuscarinic and beta-agonist) are foundational treatments.
- Inhaled corticosteroids benefit patients with frequent exacerbations; roflumilast is an option for severe COPD.
Conclusions:
- Adherence to the GOLD strategy is recommended for COPD management.
- While debate exists on pharmacotherapy's impact on mortality, it plays a crucial role.
- Non-pharmacological therapies like rehabilitation are essential components of comprehensive COPD care.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:03Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids